253 related articles for article (PubMed ID: 23131835)
1. Recurrent targets of aberrant somatic hypermutation in lymphoma.
Khodabakhshi AH; Morin RD; Fejes AP; Mungall AJ; Mungall KL; Bolger-Munro M; Johnson NA; Connors JM; Gascoyne RD; Marra MA; Birol I; Jones SJ
Oncotarget; 2012 Nov; 3(11):1308-19. PubMed ID: 23131835
[TBL] [Abstract][Full Text] [Related]
2. Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.
Spence JM; Abumoussa A; Spence JP; Burack WR
J Immunol; 2014 Nov; 193(10):4888-94. PubMed ID: 25311808
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
Xu-Monette ZY; Li J; Xia Y; Crossley B; Bremel RD; Miao Y; Xiao M; Snyder T; Manyam GC; Tan X; Zhang H; Visco C; Tzankov A; Dybkaer K; Bhagat G; Tam W; You H; Hsi ED; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Winter JN; Medeiros JT; Xu B; Li Y; Kirsch I; Young KH
J Immunother Cancer; 2019 Oct; 7(1):272. PubMed ID: 31640780
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.
Jiang Y; Soong TD; Wang L; Melnick AM; Elemento O
PLoS One; 2012; 7(7):e40332. PubMed ID: 22808135
[TBL] [Abstract][Full Text] [Related]
5. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
[TBL] [Abstract][Full Text] [Related]
6. Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma.
Benitez-Cantos MS; Cano C; Cuadros M; Medina PP
Mol Cancer; 2024 Feb; 23(1):42. PubMed ID: 38402205
[TBL] [Abstract][Full Text] [Related]
7. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
Deutsch AJ; Frühwirth M; Aigelsreiter A; Cerroni L; Neumeister P
J Invest Dermatol; 2009 Feb; 129(2):476-9. PubMed ID: 18704108
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of BACH2 is related to ongoing somatic hypermutation of the immunoglobulin heavy chain gene variable region of de novo diffuse large B-cell lymphoma.
Kikuchi T; Tokunaka M; Kikuti YY; Carreras J; Ogura G; Takekoshi S; Kojima M; Ando K; Hashimoto Y; Abe M; Takata K; Yoshino T; Muto A; Igarashi K; Nakamura N
Pathol Int; 2013 Jul; 63(7):339-44. PubMed ID: 23865571
[TBL] [Abstract][Full Text] [Related]
10. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
[TBL] [Abstract][Full Text] [Related]
11. The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.
Vater I; Montesinos-Rongen M; Schlesner M; Haake A; Purschke F; Sprute R; Mettenmeyer N; Nazzal I; Nagel I; Gutwein J; Richter J; Buchhalter I; Russell RB; Wiestler OD; Eils R; Deckert M; Siebert R
Leukemia; 2015 Mar; 29(3):677-85. PubMed ID: 25189415
[TBL] [Abstract][Full Text] [Related]
12. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Campo E; Pileri S; Pasqualucci L; Gaidano G; Falini B
Blood; 2006 Aug; 108(3):1013-20. PubMed ID: 16614247
[TBL] [Abstract][Full Text] [Related]
13. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
Pasqualucci L; Neumeister P; Goossens T; Nanjangud G; Chaganti RS; Küppers R; Dalla-Favera R
Nature; 2001 Jul; 412(6844):341-6. PubMed ID: 11460166
[TBL] [Abstract][Full Text] [Related]
14. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma.
Bödör C; Bognár A; Reiniger L; Szepesi A; Tóth E; Kopper L; Matolcsy A
Br J Haematol; 2005 May; 129(3):373-6. PubMed ID: 15842661
[TBL] [Abstract][Full Text] [Related]
15. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Crouch S; Painter D; Barrans SL; Roman E; Beer PA; Cooke SL; Glover P; Van Hoppe SJL; Webster N; Lacy SE; Ruiz C; Campbell PJ; Hodson DJ; Patmore R; Burton C; Smith A; Tooze RM
Blood Adv; 2022 Nov; 6(21):5716-5731. PubMed ID: 35363872
[TBL] [Abstract][Full Text] [Related]
16. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas.
Ye X; Ren W; Liu D; Li X; Li W; Wang X; Meng FL; Yeap LS; Hou Y; Zhu S; Casellas R; Zhang H; Wu K; Pan-Hammarström Q
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33136155
[TBL] [Abstract][Full Text] [Related]
18. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
19. Expression of the AID protein in normal and neoplastic B cells.
Pasqualucci L; Guglielmino R; Houldsworth J; Mohr J; Aoufouchi S; Polakiewicz R; Chaganti RS; Dalla-Favera R
Blood; 2004 Nov; 104(10):3318-25. PubMed ID: 15304391
[TBL] [Abstract][Full Text] [Related]
20. Aberrant somatic hypermutations in thyroid lymphomas.
Takakuwa T; Miyauchi A; Aozasa K
Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
